Growth Metrics

Zoetis (ZTS) EPS (Weighted Average and Diluted) (2016 - 2025)

Zoetis (ZTS) has disclosed EPS (Weighted Average and Diluted) for 13 consecutive years, with $1.63 as the latest value for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 8.67% to $1.63 in Q3 2025 year-over-year; TTM through Sep 2025 was $6.15, a 12.84% increase, with the full-year FY2024 number at $5.47, up 7.89% from a year prior.
  • EPS (Weighted Average and Diluted) was $1.63 for Q3 2025 at Zoetis, up from $1.61 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.71 in Q2 2024 to a low of $0.87 in Q4 2021.
  • A 5-year average of $1.37 and a median of $1.41 in 2025 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 44.66% in 2022, then fell 22.4% in 2023.
  • Zoetis' EPS (Weighted Average and Diluted) stood at $0.87 in 2021, then soared by 44.66% to $1.26 in 2022, then increased by 11.72% to $1.41 in 2023, then rose by 14.45% to $1.61 in 2024, then grew by 1.28% to $1.63 in 2025.
  • Per Business Quant, the three most recent readings for ZTS's EPS (Weighted Average and Diluted) are $1.63 (Q3 2025), $1.61 (Q2 2025), and $1.41 (Q1 2025).